TGA grants provisional determination to Roche Products Pty Ltd combination COVID-19 treatment casirivimab + imdevimab (RONAPREVE)
23 August 2021
On 20 August 2021 the Therapeutic Goods Administration (TGA) granted provisional determination to Roche Products Pty Ltd in relation to the combination therapy casirivimab + imdevimab (RONAPREVE).This combination monoclonal antibody treatment is now eligible to be considered by the TGA for the treatment of confirmed COVID-19 in patients aged 12 years and older and weighing at least 40 kg that do not require supplemental oxygen for COVID-19 and who are at high risk of progressing to severe COVID-19. RONAPREVE will also be considered for the prevention of COVID-19 in patients of the same age who have been exposed to or are at high risk of exposure to SARS-CoV-2 and/or have a medical condition that makes them unlikely to be protected by vaccination. The combination of casirivimab + imdevimab is intended to prevent serious outcomes associated with COVID-19. The two different monoclonal antibodies, casirivimab and imdevimab, bind to two different sites of the SARS-CoV-2 spike protein and flags the spike protein as 'foreign' so that other parts of the immune system can help to clear it away.
This is preventative medication. Remistemcel-L treats those who are on oxygen. Too late for this medication.
Remistemcel-L treats the symptoms of ARDS. If a person develops ARDS, it is too late for Ronapreve.
- Forums
- ASX - By Stock
- New Covid 19 treatment
TGA grants provisional determination to Roche Products Pty Ltd...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B |
Open | High | Low | Value | Volume |
$1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61090 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 239558 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61090 | 1.015 |
1 | 700 | 1.010 |
9 | 123952 | 1.005 |
34 | 516697 | 1.000 |
1 | 25000 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 17500 | 1 |
1.035 | 54000 | 2 |
1.040 | 41250 | 2 |
1.045 | 68050 | 4 |
1.050 | 45395 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online